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Ischemic stroke is a devastating disease with complex pathophysiology. Much evidence
confirms that opening of the mitochondrial permeability transition pore (MPTP) is related
with mitochondrial dysfunction to apoptosis in ischemic stroke, thus elucidating its
signaling mechanism and screening novel MPTP inhibitor is therefore of paramount
importance. Our earlier studies identified that gallic acid (GA), a naturally occurring
plant phenol, endows with effect on inhibition of mitochondrial dysfunction, which has
significant neuroprotective effect in cerebral ischemia/reperfusion injury. However, its
molecular mechanisms regulating mitochondrial dysfunction remain elusive. Here, we
uncover a role of GA in protecting mitochondria via MPTP inhibition. In addition to
inhibit CypD binding to adenine nucleotide translocator, GA potentiates extracellular
signal-regulated kinases (ERK) phosphorylation, leading to a decrease in cyclophilin D
(CypD) expression, resulting in a desensitization to induction of MPTP, thus inhibiting
caspase activation and ultimately giving rise to cellular survival. Our study firstly identifies
ERK-CypD axis is one of the cornerstones of the cell death pathways following ischemic
stroke, and confirms GA is a novel inhibitor of MPTP, which inhibits apoptosis depending
on regulating the ERK-CypD axis.
Keywords: gallic acid (GA), mitochondrial permeability transition pore (MPTP), cyclophilin D (CypD), extracellular
signal-regulated kinases (ERK), cerebral ischemia/reperfusion
Abbreviations: ANT, adenine nucleotide translocator; CPISPR, clustered regularly interspaced short palindromic repeats;
CRC, calcium retention capacity; CsA, cyclosporin A; CYP450, cytochrome P450; CypD, cyclophilin D; Cyto C,
cytochrome C; DAPI, 4′,6-diamidino-2-phenylindole; EGF, epidermal growth factor; ERK, extracellular signal-regulated
kinase; FITC, fluorescein isothiocyanate; GA, gallic acid; H & E, haematoxylin and eosin; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazol carbocyanine iodide; MCAO, middle cerebral artery occlusion; MMP, mitochondrial membrane
potential; MPTP, mitochondrial permeability transition pore; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide; NeuN, neuronal nuclei; PI, propidium iodide; rCBF, regional cerebral blood flow; ROS, reactive oxidative species;
TEM, transmission electron microscopy; TTC, 2,3,5-triphenyl-tetrazolium chloride; U0126, 1,4-diamino-2,3-dicyano-1,4-bis
[2-aminophenylthio] butadiene; VDAC, voltage-dependent anion channel.
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INTRODUCTION
Ischemic stroke is a major cause of adult disability and ranks
only behind cancer and cardiac disease as cause of death (Flynn
et al., 2008). As our current understanding of cerebral ischemia
injury is greatly contributed by the notion that mitochondria
are both a pivotal site for cell death through mitochondrial
apoptotic pathways (Andreux et al., 2013) and a central target
of processes triggered by cerebral ischemia/reperfusion, such as
elevation in intracellular Ca2+ (Sims and Anderson, 2002) and
reactive oxygen species (ROS) (Sanderson et al., 2013), it is not
surprising that strategies aimed at protecting against cerebral
ischemia/reperfusion damage have focused on mitochondria.
Mitochondria have a central role in cell death including
apoptosis, necrosis, and necroptosis via mitochondrial
membrane permeabilization (Kroemer et al., 2007; Zhang
et al., 2016). In response to pro-apoptotic stimuli, including
ROS and Ca2+ overload, the inner mitochondrial membrane
abrupt loss of permeability to small solutes (Criddle et al., 2006;
Baumgartner et al., 2009). This phenomenon, which is known
as mitochondrial permeability transition (MPT), results in
dissipation of the MMP, release of apoptotic factors, osmotic
swelling of the mitochondrial matrix, and eventually cell death
(Fulda et al., 2010; Vanden Berghe et al., 2014).
The MPT is caused by the opening of a non-selective
pore assembled at the junctions between the inner and outer
mitochondrial membrane, the so-called ‘MPT pore’ (MPTP)
(Fulda et al., 2010). While a large number of studies pointed to
various proteins such as VDAC, ANT, and F1FO ATP-synthase
complexes as to structural or regulatory MPTP components,
however, the precise molecular mechanisms of MPTP remained
a matter of debate until now (Kokoszka et al., 2004; Baines et al.,
2007; Bonora et al., 2015). As a standalone exception, CypD has
been ascribed an essential regulatory role in MPTP via robust
genetic studies as early as in 2005 (Baines et al., 2005; Schinzel
et al., 2005; Vaseva et al., 2012).
Cyclophilin D is a ppif gene product, a member of the
immunophilin family of peptidylprolyl cis-trans isomerases
(Galat and Metcalfe, 1995), which is well known bind to
mitochondrial ANT, thus promoting MPTP opening (Eliseev
et al., 2009; Fulda et al., 2010). Indeed, as a chaperone protein,
CypD promotes the rearrangement of MPTP subunits to allow
for channel formation (Galat and Metcalfe, 1995; Eliseev et al.,
2009; Bonora and Pinton, 2014). Recently study characterizes
CypD-F1FO ATP-synthase interaction from the point of view
of MPTP formation, providing evidence that CypD targets
both energy production and programmed cell death (Elrod and
Molkentin, 2013).
In line with this notion, the Ppif−/− genotype as well as
the systemic administration of chemical CypD inhibitors such
as CsA confer remarkable protection in animal models of
ischemia/reperfusion injury in vivo, and resistant to H2O2-
induced cell death in vitro (Schinzel et al., 2005; Hu et al., 2010;
Vaseva et al., 2012; Cho et al., 2013). In addition to CsA and
its derivatives, barely drugs have been validated as compounds
specifically targeting CypD or functions of MPTP (Muramatsu
et al., 2007; Martin et al., 2014). What is more, the serious adverse
reactions of these compounds limit the clinical application on
cardiovascular diseases due to their immunosuppressive effects
(Rezzani, 2004).
GA (3, 4, 5-trihydroxybenzoic acid, Figure 1F-a), an
important plant-sourced polyphenolic compound (Shen et al.,
2013), reduced non-steroidal anti-inflammatory drugs (NSAID)-
induced gastropathy, and radiation cytotoxicity by blocking
oxidative stress-mediated apoptosis (Pal et al., 2010; Timiri
Shanmugam et al., 2016). Our earlier studies identified that GA is
a potential mitochondrial protective agent, which has significant
neuroprotective effect in cerebral ischemia/reperfusion injury
(Sun et al., 2014). Nevertheless, its mitochondrial protective
mechanism remains unclear.
Here, we reveal a role of GA in protecting mitochondria
via MPTP inhibition. To our surprise, we found that GA not
only prevented MPTP opening by specifically interacted with
CypD, but also played a role in regulating CypD expression
through activating extracellular regulated protein kinases (ERK)-
dependent phosphorylation, which renders nerve cells more
refractory to MPTP opening following H2O2 (a generator of
oxidative stress) in vitro or MCAO injury in vivo. These results
confirm GA is a novel inhibitor of MPTP, which inhibits
apoptosis depending on regulating the ERK-CypD axis. To the
best of our knowledge this is the first study describing a novel
MPTP inhibitor with pharmacological effect on CypD expression.
MATERIALS AND METHODS
Chemicals, Preparation of Mitochondria,
Docking, and Experimental Design
Please see Supplementary Material.
Animals and Ethics Statement
Adult male C57BL/6 mice (18–22 g) and Sprague-Dawley rats
(250–300 g) were purchased from Jiangsu University Laboratory
Animals Center, Zhenjiang, China. All animal procedures used
in this study were approved by the Ethics Committee for
Animal Experimentation of Jiangsu University (UJS-20160012,
in Supplementary Material). The drug treatment protocols of
GA, CsA, and U0126 in this experiment were based on previous
literature (Maddahi and Edvinsson, 2008; Cho et al., 2013; Sun
et al., 2014).
Mitochondrial Calcium Retention
Capacity (CRC)
Mitochondrial CRC was assessed fluorimetrically in the
presence of the fluorescent Ca2+ indicator Calcium Green
5N by the QuantaMaster & TimeMaster Spectrofluorometer
(Photon Technology International, QuantaMasterTM40, USA)
at excitation/emission maxima of 505/535 nm. Mitochondria
(0.5 mg) were diluted in CRC buffer (120 mM KCl, 10 mM
NaCl, 1 mM KH2PO4, 10 mM MOPS, 20 mM HEPES-Tris, pH
7.2) containing 150 nM Calcium Green 5N. Mitochondria were
pulse-loaded with CaCl2 (10 µM each). Compounds were added
to the mitochondrial suspension 5 min before CaCl2 exposure.
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FIGURE 1 | Gallic acid (GA) desensitizes MPTP via a signaling axis that involves CypD in liver mitochondria. CRC was determined by the concentration of
calcium required to trigger MPTP opening.(A,B) GA has a higher Ca2+ threshold than control mitochondria. (C) CsA (1 µM) robustly increases the number of spikes,
consistent with the importance of MPTP in this process. (D) Menadione caused marked mitochondria swelling in a concentration-dependent manner, (E) whereas
GA or CsA pre-incubated mitochondria were significantly less sensitive. Histogram comparing 1A540 values (A540 max–A540 min) among groups (n = 10). (F-a)
Chemical structure of GA. (F-b) The 3D structure of CypD obtained from Protein Data Bank (PDB ID: 2BIT). (F-c) Salt bridges to ASN 102, PHE 113, MET 61, ARG
55, and (F-d) an H-bond to ASN 102 make major contributions to the binding affinity for GA (Distance: 2.039, Estimated free energy of binding: –0.568).
(G) Representative Immunoprecipitation analysis showed that Ca2+-induced increase of CypD binding to ANT-1 was blocked by CsA or GA (n = 6). GA desensitized
liver mitochondria to the permeability transition via suppressing CypD expression. (H) Mitochondria isolated from mouse liver which pre-treatment with GA
(100 mg/kg) once a day for 6 days. The level of mitochondrial swelling triggered by menadione (I) or Ca2+ (J) was significantly decreased following GA pre-treatment
(n = 10). The release of Cyto C (K), and the expression of CypD (L) were tested via Western Blotting (n = 6). COX IV, VDAC, and β-actin were used as loading
controls. Data reported as the means ± SD. P values were obtained using two-way analysis of variance (ANOVA) test. N.S. indicates a P value > 0.05. ##P < 0.01,
#P < 0.05 versus control group.
The ratio between the amounts of calcium required to trigger
MPTP in the presence of the compound (CRCi) with respect to
that required to induce MPTP in the absence of the compound
(CRCo) was used for statistical analysis.
Mitochondrial Swelling
Mitochondrial swelling assay buffer (120 mmol/L KCl,
10 mmol/L Tris-HCl, 20 mmol/L MOPS, 5 mmol/L KH2PO4, pH
7.4) containing mitochondrial solution at 1 mg/ml was placed in
each well of a 96-well plate at 25◦C. The swelling was measured
with a spectrophotometer (Molecular Device, Spectra Max 190,
USA) as a decrease in light scattering at 540 nm for 10 min.
Compounds were added to the mitochondrial suspension 5 min
before CaCl2 or menadione exposure. The difference (1A540)
between the maximum A540 value (immediately after CaCl2
or menadione addition) and the minimum A540 value (10 min
after CaCl2 or menadione addition) were used for statistical
analysis.
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Immunoprecipitation
After pre-treatment with compounds for 5 min and 100 µM
CaCl2 exposured to 10 min, the isolated liver mitochondria were
lysed in PBS containing 1% TritonX-100 and protease inhibitors
cocktail. The supernatant was precleared with Protein A/G beads
for 2 h at 4◦C, and 500 mg of precleared protein extracts were
incubated with 1 µg of anti-CypD antibody or normal rabbit
IgG overnight at 4◦C. The precipitated complexes were washed
in lysis buffer and bound proteins analyzed by immunoblots.
Western Blotting
Samples were prepared to isolation of mitochondria and
cytosolic protein by a mitochondria isolation kit according
to the manufacturer’s guidelines. Equal amounts of proteins
were resolved by SDS/polyacrylamide gel electrophoresis (PAGE)
using 10–15% acrylamide, transferred onto polyvinylidene
difluoride (PVDF) membranes, and blotted using the following
commercially available antibodies: anti-CypD (1:500), anti-ANT
(1:300), anti-VDAC (1:400), anti-Cyto C (1:300), anti-Caspase-3
(1:500), anti-Caspase-8 (1:300), anti-Cleaved-Caspase-9 (1:400),
anti-ERK1/2 (1:500), and anti-p-ERK1/2 (1:500), anti-β-actin
(1:4000), anti-COX IV (1:500) followed by incubation with
the corresponding horseradish peroxidase-labeled secondary
antibody (1:2000). Protein bands were visualized and analyzed
using the Chemifluorescence Imaging Systems (GE, USA).
Induction of Transient Cerebral Ischemia
Transient cerebral ischemia was induced by MCAO according to
the method of Longa et al. (1989). The rats were anesthetized
with chloral hydrate (350 mg/kg intraperitoneal injection).
To alleviate pain, animals received 0.05 mg/kg subcutaneous
buprenorphine immediately after the reperfusion anesthesia. The
level of rCBF was achieved using a laser-Doppler flowmeter
(Moor Instruments, UK). Rats had a rCBF in 20% of the pre-
ischemic baseline value 10 min after ischemia and to the 80%
of baseline at 30 min after reperfusion were used in this study
(Mao et al., 2015). Physiological parameters such as the mean
arterial blood pressure and heart rate were all monitored by
Power Lab System (AD Instruments, Australia). The rats in
the sham operation group underwent vessel exposure without
MCAO. Body temperature was regulated at 37.0 ± 0.5◦C with
a heating pad and lamp when necessary. The details of the
exclusion criteria, the level of rCBF, and physiological parameters
were shown in the Supplementary Material.
Assessment of Cerebral Infarct Volume
2,3,5-Triphenyl-tetrazolium chloride staining was carried
out using methods previously published by Leker et al.
(2003). Brain Infarct volumes were calculated according to
the following formula: (contralateral volume-undamaged
ipsilateral)/contralateral volume (%).
Histopathological Analysis
Rat brains were removed, fixed in 4% paraformaldehyde in
phosphate-buffered saline for 72 h at room temperature,
dehydrated through a graded ethanol series, and embedded in
paraffin. Sections of 4–5 µm thick were cut in the coronal
plane and stained with H & E staining, which was performed as
previously described (Monaghan et al., 2016).
Immunostaining
Immunostaining methods were used as described previously
(Fernandez-Godino et al., 2016). The following primary
antibodies were used: anti-Cyto C (1:150), anti-Cleaved-
Caspase-9 (1:100), and anti-NeuN (1:200). Following incubation
with the primary antibody at 4◦C overnight, sections were
incubated for 90 min with Alexa Fluor 594-and Alexa Fluor 488-
conjugated secondary antibodies (1:200) in blocking solution at
room temperature. Finally, sections were incubated with DAPI
for 10 min to detect nuclei. All the slices were visualized by
fluorescent inverted microscope (Nikon, Ti-E Live Cell Imaging
System, Japan).
Electron Microscopy
Rats brains were removed, dissected, and the ipsilateral
penumbra areas post-fixed in the same fixative for 2 h before
transferring to 0.12 M PBS. Specimens were immersed in 1%
OsO4 in cacodylate buffer, dehydrated in ethanol and embedded
in epoxy resin. Ultrathin sections (60 nm) were obtained with
an ultra microtome (Leica EM UC7) and then were stained
with uranyl acetate and lead citrate for examination with a
transmission electron microscope (TEM) at 80 kV (HITACHI,
H-7650, Japan).
Cell Cultures and Treatments
Human neuroblastoma SH-SY5Y cells were cultured in 90%
modified Eagle’s medium-F12 medium and supplemented with
10% fetal bovine serum. All cultures were maintained in 10 cm
tissue culture dishes to approximately 90% confluence in a
humidified atmosphere of 5% CO2-95% air at 37◦C. The SH-
SY5Y cells were treated with H2O2 at concentration of 500 µM
for 4 h to establish the MPTP opening. Various concentrations
of GA (0.1, 1, 10 µM), EGF (10, 100 ng), and CsA (1 µM) were
added into the cultures 24 h before the onset of H2O2-inducing
MPTP opening. Cells were incubated with U0126 (1, 10 µM)
in culture medium for 2 h before GA or EGF treatment, which
was used to inhibit ERK phosphorylation as recommended by the
manufacturer.
Plasmid Transfection
Clustered regularly interspaced short palindromic repeats-CypD
plasmid synthesized by Santa Cruz Biotechnology was transfected
into SH-SY5Y cells using the UltraCruz Transfection Reagent.
Samples were collected at 24 and 48 h, and the transfection
efficiency was examined by Western bolt. According to the
manufacturer’s instructions and our experiment data, the cells
were used following 48 h transfection. Control cells were treated
control CRISPR activation plasmid in an identical way.
Cell Viability and Apoptosis
Cell viability was measured by MTT assay (Ganot et al., 2013).
The optical density was spectrophotometrically measured at
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570 nm using a microplate reader (Molecular Device, Spectra
Max 190, USA) with DMSO as the blank. Cell apoptosis was
determined by the Annexin V-FITC/PI apoptosis detection kit.
A total of 20,000 cells of each sample were analyzed by bivariate
flow cytometry system (Becton-Dickinson, FACSCanto II, USA).
Assaying MPTP Opening in Live Cells
To obtain direct evidence of GA effect on MPTP, the Calcein
AM-CoCl2 assay was performed as previously described (Bonora
et al., 2016). The results were visualized using fluorescent
inverted microscope (Nikon, Ti-E Live Cell Imaging System,
Japan). Alternatively, fluorescence intensity was monitored using
flow cytometry (Becton-Dickinson, FACSCanto II, USA) at
excitation/emission maxima of 490/515 nm.
Assessment of Mitochondrial Membrane
Potential (MMP)
A cationic dye, JC-1, was used to monitor the MMP. Briefly,
cells were treated JC-1 10 µM for 30 min incubation at 37◦C.
The results were visualized using fluorescent inverted microscope
(Nikon, Ti-E Live Cell Imaging System, Japan). Alternatively,
fluorescence intensity was monitored using flow cytometry
(Becton-Dickinson, FACSCanto II, USA) at excitation/emission
maxima of 585/590 nm (J-aggregates) and 514/529 nm
(monomer).
Statistical Analyses
Except neurological deficit scores, all values are expressed as
the mean ± SD, and the statistical significance of difference
between groups was determined by a two-way analysis of variance
(ANOVA) test. Neurological deficit scores were expressed as the
median, and the statistical significance of the difference between
groups was determined by a non-parametric Mann Whitney
test. A P-value < 0.05 was considered to indicate statistical
significance.
RESULTS
GA Inhibits MPTP in Liver Mitochondria
in both Ca2+ and ROS Stimuli
Matrix Ca2+ is the single most important factor for inducing
MPTP (Baumgartner et al., 2009; Fulda et al., 2010). Here,
mitochondrial CRC was assessed fluorimetrically in the presence
of the fluorescent Ca2+ indicator Calcium Green 5N. As shown
in Figure 1, control mitochondria buffered 30 µM CaCl2, and
their buffering capacity was significantly increased after pre-
incubation with 1 µM CsA, consistent with the importance
of MPTP in this process (Figures 1A,C and Supplementary
Table 1; n = 10, P < 0.01). As expected, mitochondria that pre-
incubation with 10 µM GA buffered up to 60 µM CaCl2, strongly
increased the level of CRC as observed in control mitochondria
(Figures 1A,B and Supplementary Table 1; n= 10, P < 0.01).
We further assessed MPTP sensitivity to the oxidant
menadione, which acts as a potent MPTP inducer through
promoting oxidative stress (Criddle et al., 2006). The1A540 value
of the mitochondria exposed to menadione at concentrations of
50–200 µM for 10 min increased to 0.1566± 0.01, 0.1975± 0.02,
and 0.2203 ± 0.01 of the control value, respectively (Figure 1D;
n = 10). Menadione caused marked mitochondria swelling,
whereas CsA pre-incubated mitochondria were significantly less
sensitive (Figure 1E; n = 10, P < 0.01). Importantly, GA
prevent mitochondrial swelling induced by stimuli independent
of calcium overload (Figure 1E; n = 10, P < 0.05), suggesting
that it act as a genuine inhibitor of MPTP and not by affecting the
calcium homeostasis.
GA Protects Brain Mitochondria against
Cerebral Ischemia Reperfusion Injury
Next, we are interested in the MPTP activity of GA in cerebral
ischemia insult, which is well known to favor activation of
MPTP in vivo (Sun et al., 2012; Sanderson et al., 2013). The
preliminary experiment is conducted to determine the time
limited term under MCAO condition (Supplementary Figure 1;
n = 4, P < 0.05). No neurological deficits were observed in
the sham treated rats, whereas rats subjected to MCAO were
scored 2, 3, or 4 in the neurological assessment (Supplementary
Figure 5A; n = 20, P < 0.01). The neurological deficits score
in GA 50 mg/kg or CsA 10 mg/kg group was significantly
reduced (Supplementary Figure 5A; n = 20, P < 0.05). By
immunostained with NeuN, the numbers of pyramidal neurons
in the hippocampus region were diminished dramatically after
reperfusion, whereas the loss of hippocampal neurons was
attenuated by GA (Figures 2F-a,b). The expression of cleaved-
caspase-3, 8 and number of cleaved-caspase-9-positive cells (%
of DAPI+ cells) were dramatically increased in the MCAO
group compared with sham group, suggesting that both intrinsic
and extrinsic apoptosis were trigged in cerebral ischemia
(Figures 2A,C–E-a5,b5,H; n = 4, P < 0.01). Compared with the
MCAO group, pre-treatment with GA had unequally sensitive in
expression of cleaved-caspase-8 (Figures 2A,C; n = 4, P > 0.05)
and the number of cleaved-caspase-9-positive cells (% of DAPI+
cells) (Figures 2E-b5,c5,H; n = 4, P < 0.01), suggesting that
GA alleviates neuronal apoptosis dependent in the mitochondrial
apoptotic pathways.
Moreover, the mitochondrial protective effect of GA was
further measured by the TEM and TTC assay. Notably, while
the outer and inner membranes of mitochondria in sham
group were clearly distinguishable, the mitochondria showed
robustly swelling, vacuolization, disruption and loss of cristae
following 48 h reperfusion (Figures 2E-a3,b3). This brought
considerable relief in mitochondrial ultrastructure by pretreated
with GA or CsA, which the cristae were slightly disrupted
(Figures 2E-c3,d3), and the infarct volume was significantly
reduced in GA pre-treatment (Figures 2E-b1,c1,G; n = 8,
P < 0.01) further confirmed that GA effectively protects brain
mitochondria against ischemia/reperfusion injury.
GA Inhibits Cell Death and MPTP in
Cultured SH-SY5Y Cells
Since our in vivo data indicated MPTP is a key target of GA
in pathologic neuron apoptosis, we next focus on validate this
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FIGURE 2 | Gallic acid protects neuron against MCAO insult by the mitochondrial-dependent pathway. GA downregulated brain mitochondrial CypD,
inhibited the expression of Cleaved-caspase-8, and Cleaved-caspase-3 protein levels in brain mitochondria following transient cerebral ischemia (n = 4; A–D). VDAC,
and β-actin were used as loading controls. GA protected brain mitochondrial and confers neuron survival after transient cerebral ischemia. (E-a1–d1) Representative
TTC-stained coronal brain sections; white indicates infarcted tissue. (E-a2–d2) Representative H & E stained coronal brain sections (n = 4). Scale bars, 10 µm.
(E-a3–d3) The TEM results evidence that GA protected brain mitochondria against MCAO injury (n = 4). Scale bars, 1 µm. (E-a4–6, b4–6, c4–6, d4–6)
Immunohistochemistry depicting colocalization of Cleaved-caspase-9 with NeuN following 48 h reperfusion. Scale bars, 10 µm. (F) The numbers of pyramidal
neurons in the hippocampus region were also diminished by Immunohistochemistry. Scale bars, 10 µm. (G) Histogram showing the infarct volume (% of
contralateral hemisphere) in TTC-stained brain sections (n = 8). (H) Histogram showing the percentage of NeuN and Cleaved-caspase-9-positive cells which
described as the number of positive cells/total number of cells (n = 4). Data reported as the means ± SD. P values were obtained using two-way analysis of variance
(ANOVA) test. ##P < 0.01, #P < 0.05 versus sham group. ∗∗P < 0.01, ∗P < 0.05 versus MCAO group.
idea in vitro. Compared to the control group, H2O2 group was
significantly decreased the cell viability (% of control) at 500 µM
(Supplementary Figure 2; n = 5, P < 0.01), and the number
of apoptotic and necrotic cells were significantly increased, in
accordance with the morphological observations (Figures 3A-
a1,a2,b1,b2,C,D; n = 5, P < 0.01). Notably, H2O2 elicited a
rapid and almost complete decrease in the fluorescent density of
mitochondrial calcein, a highly selective indicator of sustained
MPTP opening in situ (Vaseva et al., 2012; Chen et al., 2015),
while it was significantly reversed in the CsA pre-treated cells
confirming loss of signal resulted from H2O2-induced opening of
MPTP in our system (Figures 4A-a2–a4,b2–b4,e2–e4,B; n = 4,
P < 0.01). This observation was in striking contrast to GA pre-
treated cells, which considerably less SH-SY5Y cells mortality
or apoptosis and retained more levels of calcein fluorescence
than H2O2 treated cells in a concentration-dependent manner
(Figures 3A-b1,b2,e1,e2,B,C, 4A-b2,b4,c2,c4,d2,d4,B; n = 4–5,
P < 0.01).
As MMP could immediate dissipated by MPTP activation
(Fulda et al., 2010), the level of the MMP by JC 1 assay were
also examined in this work. Compared to the control group, the
red/green fluorescence intensity ratio in H2O2 treatment SH-
SY5Y cells was significantly decreased (Figures 4A-a5–a7,b5–
b7,C; n = 4, P < 0.01), while GA or CsA effectively blocked
Frontiers in Pharmacology | www.frontiersin.org 6 April 2017 | Volume 8 | Article 184
fphar-08-00184 April 4, 2017 Time: 15:3 # 7
Sun et al. GA Inhibits MPTP via ERK-CypD Axis
FIGURE 3 | Gallic acid inhibits H2O2-induced SH-SY5Ys death by modulating the intrinsic pathway. The mortality and apoptosis of SH-SY5Y cells were
considerably less following pretreated with GA. (A-a2–f2) The number of apoptosis cells were detected by flow cytometry, in accordance with the morphological
observations (A-a1–f1). Histogram showing the percentage of cell viability (B), apoptosis (C) and necrosis cells (D), which described as the number of positive
cells/total number of cells (n = 5). GA inhibited the expression of mitochondrial apoptotic signaling molecules induced by H2O2. Western Blotting (E), and
quantification (F,G) the relative intensities of the bands in each sample by quantity software (n = 4). Scale bars, 5 µm. Data reported as the means ± SD. P values
were obtained using two-way analysis of variance (ANOVA) test. ##P < 0.01, #P < 0.05 versus control group. ∗∗P < 0.01, ∗P < 0.05 versus H2O2 group.
this event, consistent with the results of Calcein-CoCl2 assay
(Figures 4A-b5–b7,d5–d7,e5–e7,C; n = 4, P < 0.01). These
data further confirmed that GA could suppress oxidative stress-
induced MPTP and cell death.
GA Inhibits SH-SY5Y Cells Death via the
Mitochondrial Apoptotic Pathways
As a second line of evidence for the inhibition of GA on
MPTP, the expression of mitochondrial apoptotic signaling
molecules, including the initiator Cyto C, mediator caspase-
9, and effector caspase-3 were measured by Western Blot. As
shown in Figure 3E, the release of Cyto C, the expression of
cleaved-caspase-9 and -3 were observed with a 4-, 9-, and 7-
fold increase, respectively, when compared to the control cells
(Figures 3E,F,G,4A-a1,b1; n = 4, P < 0.01). Notably, compared
with H2O2 treated cells, GA significantly reduced the expression
of Cyto C, cleaved-caspase-9 and -3 confirming that GA inhibits
H2O2-induced cells death by MPTP inhibition (Figures 3E,F,G,
4A-b1,d1; n= 4, P < 0.05).
GA Directly Inhibits CypD Binding to
ANT-1 in Liver Mitochondria
Of note, CypD is well known bind to mitochondrial ANT, thus
promoting MPTP opening (Eliseev et al., 2009; Fulda et al., 2010).
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FIGURE 4 | Gallic acid desensitizes the MPTP induced by H2O2 in a CypD-dependent manner. GA decreased the sensitivity of H2O2-induced MPTP
induction in SH-SY5Y cells. (A-a1–e1) Representative endogenous Cyto C release in SH-SY5Y cells by Immunofluorescence analysis. (A-a2–e2) MPTP determined
by Calcein-CoCl2 fluorescence. (A-a3–e3) Higher magnification and quantification (A-a4–e4) the calcein fluorescence tested by flow cytometry. The representative
images show JC-1 aggregates (A-a5–e5), monomers images (A-a6–e6), and quantification (A-a7–e7) the JC-1 by flow cytometry, respectively. Histogram showing
the level of calcein fluorescence (B), and the ratio of JC-1 aggregates to JC-1 monomers (C; n = 4). Therapeutic effect of GA on MPTP inhibition was reversed by
overexpression of CypD in SH-SY5Y cells. (D) Western blotting (upper) and quantification (lower) for mitochondrial CypD in SH-SY5Y cells pre-treated with GA or
CsA following H2O2 for 4 h (n = 4). (E) Transfection efficiency was examined with Western Bolting. VDAC was used to loading control. (F-a1,a2) The levels of calcein
fluorescence transfected with CypD or plasmid control, and treated with (F-c1,c2) or without (F-b1,b2) GA under H2O2 conditions were (G) quantificated by flow
cytometry (n = 4). Scale bars, 5 µm. Data reported as the means ± SD. P values were obtained using two-way analysis of variance (ANOVA) test. N.S. indicates a P
value > 0.05. ##P < 0.01, #P < 0.05 versus control group. ∗∗P < 0.01, ∗P < 0.05 versus H2O2 group.
Here, the physical interaction between CypD and ANT-1 was
markedly enhanced by Ca2+ incubation, and prevented by CsA,
consistent with these reports mentioned above (Figure 1G). GA
abrogated Ca2+-induced CypD binding to ANT-1, indicating
that the beneficial effects of GA are mediated, at least in part,
by decreasing in CypD associated with ANT-1, subsequently
blocking MPTP (Figure 1G). Moreover, the results of molecular
docking between GA and CypD showed that GA was able to form
electrostatic forces with ASN 102, PHE 113, MET 61, ARG 55 of
CypD (Figure 1F-c). Notably, there is a hydrogen bond between
GA and the residue ASN 102 of CypD (Distance: 2.039, Estimated
free energy of binding: −0.568) (Figure 1F-d), in addition the
binding site was correlated with previously reported binding site
of CypD where CsA was bound (Kajitani et al., 2008).
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CypD Is Suppressed by GA both In vivo
and In vitro
Interestingly, mitochondria isolated from mouse liver in the
pre-treatment with GA once a day for 6 days (Figure 1H)
were desensitized to the permeability transition, and the level
of mitochondrial swelling triggered by Ca2+ or menadione was
significantly decreased compared with the control mitochondria
(Figures 1I,J; n = 10, P < 0.01). Importantly, it seemed more
valence compared with mitochondria pre-treated GA 10 µM
mentioned above, indicating that there may be other mechanisms
at work. Western blotting data showed that not VDAC but CypD
expression was significantly suppressed in liver mitochondria
(Figure 1L; n = 6, P < 0.05), suggesting that CypD is a
potential target of GA in regulating the sensitivity of MPTP in
the isolated mitochondria. Moreover, no significant difference in
the release of Cyto C was observed in all samples, confirmed that
the mitochondrial membrane remains well (Figure 1K; n = 6,
P > 0.05).
We reproduce this phenomenon in the cultured SH-SY5Y
cells. As shown in Figure 4D, oxidative stress mediated by H2O2
caused greatly increase the expression level of CypD (Figure 4D;
n = 4, P < 0.01). Compared with H2O2 treated cells, SH-
SY5Y cells exposed to 0.1 or 10 µM of GA for 24 h displayed
significantly decreased levels of CypD expression (Figure 4D;
n = 4, P < 0.01). Importantly, it was worth noting that the
decrease in brain mitochondrial CypD expression is indicative of
the ability of GA to cross the blood-brain barrier, and suggesting
that CypD is responsible for therapeutic benefit by GA via effects
on MPTP inhibiting (Figures 2A,B; n= 4, P < 0.01).
CypD Overexpression Abrogates
GA-Induced MPTP Desensitization
To further evaluate whether CypD is essential for the sensitivity
of GA in MPTP, cells were transfected with CPISPR-CypD to
overexpress CypD. Incubation of SH-SY5Y cells with a CPISPR-
CypD resulted in 120% increasing in CypD protein levels after
48 h transfection (Figure 4E; n = 4, P < 0.01). As shown
in Figure 4F, SH-SY5Y cells overexpress CypD tended no
significant loss of calcein fluorescence than non-transduced cells
treated by 500 µM of H2O2 (Figures 4F-b1,b2,G; n = 4,
P > 0.05). Importantly, the calcein fluorescence signal in the
GA pretreated cells was significantly higher than H2O2 treated
cells (Figures 4F-b1,c1,G; n = 4, P < 0.01), however, there was
no significant charged in CypD overexpression SH-SY5Y cells
following GA pretreated (Figures 4F-b2,c2,G; n = 4, P > 0.05).
These results confirmed that the inhibition of H2O2-induced
MPTP by GA is dependent on CypD.
In vitro Modification of the ERK
Phosphorylation Status Alters CypD
Expression
Of note, ERK is involved in mitochondrial dysfunction during
both apoptotic and autophagy cell death-inducing pathways
(Monick et al., 2008; Martinez-Lopez et al., 2013). As showed
in Figure 5, EGF activated ERK in a concentration dependent
manner, and it exerted the best effect at a concentration of 100 ng
for 1 h (Figures 5A,B; n = 4, P < 0.05). As expected, the level
of phosphorylation ERK (p-ERK) were significantly inhibited
by pre-treatment with U0126, a specificity inhibitor of ERK
phosphorylation, at a concentration of 10 µM (Figures 5A,B;
n= 4, P< 0.01). In comparison with control cells, U0126 strongly
increased the expression of CypD following 24 h of exposure,
while EGF has the exactly opposite effect to that of CypD
expression (Figures 5A,C; n = 4, P < 0.05). Importantly, U0126
reversed the EGF-induced CypD overexpression, suggesting
that the CypD expression in SH-SY5Y cells, at least in part,
depends on ERK phosphorylation (Figures 5A–C; n = 4,
P < 0.05).
Additionally, to explore whether CypD also regulated the
phosphorylation of ERK, SH-SY5Y cells were transfected
CPISPR-CypD to overexpress CypD. Incubation of SH-SY5Y
cells with a CPISPR-CypD resulted in 105% increasing in CypD
protein levels after 48 h transfection (Figures 5G,H; n = 4,
P< 0.01). Compared with the control cells, CypD overexpression
had no effect on the level of p-ERK, suggesting that CypD was
a downstream target protein of ERK (Figures 5G,I; n = 4,
P > 0.05).
Alteration of CypD Expression by ERK
Phosphorylation in MCAO Rats
As a second line of evidence for the signaling of ERK-
CypD, the effect of ERK in CypD expression during cerebral
ischemia/reperfusion injury were studied in vivo. Of note, robust
induction of p-ERK was expressed in the ischemic penumbra at
the early stage of reperfusion, which involved in neuronal loss
through caspase-3-mediated apoptosis (Li et al., 2002; Liang et al.,
2014). In comparison with sham rats, the level of p-ERK were
significantly increased at 24 h, strongly declined at 48 h, and
recovered at 72 h in the ischemic penumbral region following
cerebral ischemia/reperfusion injury (Figures 5D,E; n = 4,
P< 0.01). Similarly, corresponds to overexpression of p-ERK, the
expression of CypD were significantly decreased at 24 h, while
robustly increased at 48 h after cerebral ischemia/reperfusion
injury (Figures 5D,F; n = 4, P < 0.05). Importantly, compared
with sham group, the cleaved-caspase-3 were dramatically
increased at 48 h following cerebral ischemia/reperfusion injury
(Supplementary Figure 1; n= 4, P< 0.05), further indicating that
CypD-ERK axis involved in neuronal apoptosis at the early stage
of reperfusion.
ERK Mediates GA-Induced
Cytoprotective Effect via CypD
Downregulation
Since our data identified that phosphorylation of ERK is an
early signaling event before the expression of CypD, whether
ERK signaling participate in GA-induced CypD expression was
determine. In SH-SY5Y cells, the phosphorylation of ERK is
elevated in cells exposed to GA for 1 h when compared with
control group (Figures 5K,L, 6A,D; n = 4, P < 0.05). Notably,
the GA-induced downregulation of CypD was abrogated by
U0126, suggesting that the effect of GA on CypD, at least
in part, results in an enhancement of ERK phosphorylation
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FIGURE 5 | Gallic acid alters CypD expression results in an enhancement of ERK phosphorylation. The expression of CypD in SH-SY5Y cells partly
depends on ERK phosphorylation. (A) the phosphorylation of ERK and the expression of CypD were determined by immunoblotting at 1 and 24 h following GA or
EGF treatment, respectively. t-ERK and VDAC were used as a loading control. (B,C) Histogram showing the relative intensities of the bands in each sample was
semi-quantification by quantity software (n = 4). ##P < 0.01, #P < 0.05 versus control group. ∗∗P < 0.01, ∗P < 0.05 versus EGF (100 ng) group. (D–F) Transient
cerebral ischemia increases ERK activity and downregulates CypD. The methods of tested and calculated the level of p-ERK and CypD were identical to (A; n = 4).
##P < 0.01, #P < 0.05 versus sham group. ∗∗P < 0.01, ∗P < 0.05 versus Reperfusion 24 h group. CypD was a downstream target protein of ERK. (G) Transfection
efficiency was examined with Western bolt. (H,I) The phosphorylation of ERK and the expression of CypD were determined by immunoblotting (n = 4). (J) The design
for the in vitro experiment in (K–M) GA altered CypD expression through potentiating ERK phosphorylation. The methods of tested and calculated the level of p-ERK
and CypD were identical to (A; n = 4).##P < 0.01, #P < 0.05 versus control group. ∗∗P < 0.01, ∗P < 0.05 versus U0126 (10 µM) group. Data reported as the
means ± SD. P values were obtained using two-way analysis of variance (ANOVA) test.
(Figures 5K–M, 6A,E; n= 4, P< 0.01). The neurological deficits
score in GA 50 mg/kg or U0126 30 mg/kg group was significantly
reduced (Supplementary Figure 5B; n= 12, P > 0.05). Moreover,
while U0126 significantly reduced the percent of the infarct
volume and the expression of cleaved-caspase-3 following MCAO
insult in vivo (Figures 6H–J,L; n= 4–8, P < 0.05), no significant
difference in the level of calcein fluorescence between U0126 and
H2O2 group in vitro (Figures 6B-c,d,e,C; n= 4, P > 0.05).
While GA was able to desensitize the MPTP in a
CypD-dependent manner, whether this protection effect
was related to ERK phosphorylation was investigated. As shown
in Figure 6, combination treatment with U0126 abrogated
GA-induced CypD downregulation, MPTP inhibition, and
promoted caspase activation in vitro (Figures 6A,B-c,d,f,C,F;
n = 4, P > 0.05) and in vivo (Figures 6H–L; n = 4, P > 0.05),
further confirmed the idea that ERK mediates GA-induced
cytoprotective effect via CypD downregulation.
DISCUSSION
Here, for the first time, it demonstrates that the natural GA is a
novel small molecule inhibitor of MPTP, which established this
neuroprotective effect depending on regulating the ERK-CypD
axis. Moreover, they are in contradiction with previous reports
that inhibiting ERK phosphorylation could significantly attenuate
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FIGURE 6 | Extracellular signal-regulated kinases mediates GA-induced cytoprotective effect via CypD downregulation. ERK is necessary for GA to
prevent H2O2-induced apoptosis via CypD downregulation. (A) The phosphorylation of ERK and the expression of CypD were determined by immunoblotting.
t-ERK, VDAC, and β-actin were used as a loading control. The design for the in vitro experiment in this figure was shown in (B-a). (B-b–f) MPTP determined by
Calcein-CoCl2 assay and (C) quantification by flow cytometry (n = 4). (D–F) Histogram showing the relative intensities of the bands in each sample was
semi-quantification by quantity software (n = 4). ##P < 0.01, #P < 0.05 versus control group. ∗∗P < 0.01, ∗P < 0.05 versus H2O2 group. ERK signaling triggered by
GA were involved in MCAO-mediated apoptosis in rats. (G) The design for the in vivo experiment in this figure. (H) Representative TTC-stained coronal brain
sections; white indicates infarcted tissue. (I) The phosphorylation of ERK and the expression of CypD were determined by immunoblotting. (J) Histogram showing
the infarct volume (% of contralateral hemisphere) in TTC-stained brain sections (n = 8). (K,L) Quantification the bands in each sample was semi-quantification by
quantity software (n = 4). ##P < 0.01, #P < 0.05 versus sham group. ∗∗P < 0.01, ∗P < 0.05 versus MCAO group. Data reported as the means ± SD. P values were
obtained using two-way analysis of variance (ANOVA) test.
apoptosis following cerebral ischemia/reperfusion injury (Wang
et al., 2003; Wang T. et al., 2015).
Mitochondrial permeability transition pore results from
relatively severe perturbations of intracellular redox and/or Ca2+
homeostasis, such as those that can be artificially imposed
by ionophores (e.g., CaCl2) or potent oxidants (e.g., H2O2,
menadione) in vitro (Vaseva et al., 2012; Chen et al., 2015), or
those that are caused by ischemia/reperfusion insults in vivo
(Schinzel et al., 2005; Sun et al., 2012). Earlier studies by
our group identified that GA is a potential mitochondrial
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FIGURE 7 | Model illustrating the mechanism of cytoprotective effect by GA. In addition to inhibit CypD binding to ANT, GA potentiates ERK phosphorylation,
leading to a decrease in CypD expression, resulting in a desensitization to induction of MPTP, thus inhibiting caspase activation and ultimately giving rise to cellular
survival.
protective agent, which has significant neuroprotective effect
in cerebral ischemia/reperfusion injury (Sun et al., 2014).
Here, pretreatment with GA has a higher Ca2+ threshold,
more refractory to mitochondrial swelling, calcein fluorescence
and MMP dissipated induced by potent oxidants, deepen the
knowledge on molecular actions triggered by GA, which result
in MPTP inhibition. GA significantly reduced the expression of
mitochondrial apoptotic signaling molecules further verify the
above results. This similar results were also observed in vivo.
Of note, cerebral ischemia triggers both intrinsic pathway that
originates from mitochondrial crash associated stimulation of
caspase-9 and the extrinsic pathway that derives from death
receptors activation and subsequent stimulation of caspase-8
(Broughton et al., 2009). GA brought considerable relief in
brain mitochondrial ultrastructure, and had unequally sensitive
in caspase-8 and 9 activation, emphasizing that GA alleviates
neuronal apoptosis dependent in the mitochondrial apoptotic
pathways. Totally, these in vivo and in vitro data demonstrated
that GA is a genuine inhibitor of MPTP.
Indeed, cells depleted of putative core components of MPTP
or treated with pharmacological modulators thereof exhibit an
altered sensitivity to MPTP induction. However, whereas the
generation of Ppif−/− mice and mice pretreatment with CsA
formally attributed to CypD a key function in the molecular
cascades that precipitate MPTP (Baines et al., 2005; Schinzel
et al., 2005; Hu et al., 2010; Vaseva et al., 2012; Cho et al.,
2013), the simultaneous knockout of Slc25a4/5 (encoding ANT-
1/2) or VDAC-1/2/3 failed to protect specific cells from MPTP
induction in mouse (Kokoszka et al., 2004; Baines et al., 2007).
At present, not VDAC but CypD were in significant depletion
of GA affected cells both in vivo and in vitro, which abolished
by CypD overexpression confirming GA desensitizes the MPTP
induced by H2O2 is CypD dependent. This may explain why
pretreated with GA was equally well protected SH-SY5Y cells
from MPTP induction induced by H2O2 as CsA group, while
GA has lower potency as a CypD inhibitor when compared
with CsA. Thus, our findings confirmed that GA modulated the
sensitivity of the MPTP through direct and indirect-interference
with CypD.
The quest for key upstream regulators of the CypD yielded
no better results. Actually, the transient or stable knockdown
of p53, glycogen synthase kinase 3β, as well as F1FO ATP-
synthase, has been shown to modulate the sensitivity of
cultured cells to MPTP-inducing stimuli by binding to CypD
(Nishihara et al., 2007; Vaseva et al., 2012; Elrod and Molkentin,
2013). In particular, only a few of these proteins have been
mechanistically implicated in MPTP in vivo so far. Here, ERK has
been etiologically implicated in brain injury following cerebral
ischemia/reperfusion owing to its ability to inhibit MPTP by
downregulating CypD expression, and the resistance displayed by
GA were abrogated by co-administration of U0126 in vitro and
in vivo, further confirming that the neuroprotective effect of GA
is depending on regulating the ERK-CypD axis.
Of note, robust induction of ERK was expressed in the
ischemic penumbra at the early stage of reperfusion, which
involved in neuronal loss through caspase-3-mediated apoptosis
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(Li et al., 2002; Liang et al., 2014). At present, the cleaved-caspase-
3 were dramatically increased at 48 h following reperfusion,
while the expression of ERK were decreased, which provides
a direct approach in understanding the phosphorylation of
ERK is beneficial to the recovery of neurons after cerebral
ischemia. Our results challenge the view that inhibiting ERK
activation could prevent neuronal damage following cerebral
ischemia/reperfusion injury (Wang et al., 2003; Wang T. et al.,
2015). At present, while U0126 has significant neuroprotective
effect in cerebral ischemia/reperfusion injury, it did not
promote cell survival following H2O2 injury. Of note, CypD-
regulated MPTP is a crucial event during H2O2-induced
cell death, definitively established by the CypD knockout
mice (Baines et al., 2005; Vaseva et al., 2012). Hence, the
failure of U0126 for H2O2-induced cell death could be
understand to their inability to modulate MPTP. Importantly,
ERK phosphorylation-induced apoptosis is activated in a
Ca2+/Calmodulin (CaM)-dependent manner following cerebral
ischemia (Zhao et al., 2008). Despite GA probably not
only targeted ERK-CypD pathway, the successful of GA as
ERK activator for experimental stroke may be due to their
ability to direct modulate mitochondrial CRC via MPTP
inhibition.
Additionally, though GA has significant neuroprotective
effects by inhibiting MPTP, the influence on the regulation of
CYP450 by GA could not be ignored. Several studies have
revealed that GA weakly and time-dependently inactivated
CYP3A4 via its oxidative products, leading to more potential
for toxicity of co-administered drugs (Stupans et al., 2002;
Pu et al., 2015; Vijayakumar et al., 2015). Of note, CYP3A4
plays a key role in metabolic clearance of Nifedipine and
Amlodipine in humans, which were commonly prescribed
calcium channel blocker for the treatment of hypertension (Zhu
et al., 2014; Wang X.F. et al., 2015). As a major cardiovascular
risk factor for stroke, many patients of ischemic stroke are
taking hypertensive medications (Bartsch et al., 2013). Blind
applying GA in stroke patients suffered from hypertension
will be blocked the metabolism of calcium antagonists, and
may cause adverse reactions. Therefore, detailed studies on the
interaction of GA and cardiovascular drugs have important
practical significance, in which, the regulating of CYP450 systems
are often required.
CONCLUSION
This study identifies GA is a novel MPTP inhibitor, which
might be promising for the treatment of stroke. We confirms
CypD as a target protein through which GA exposure suppress
the sensitivity of mitochondria to induction of MPTP, and
proposes a model explaining the possible mechanism behind
the downregulation CypD by GA in Figure 7. In consideration
that MPTP plays a crucial role in mediating mitochondrial
dysfunction cause for oxidative stress, we believe that GA could
be beneficial in the treatment of wide variety of diseases (Sun
et al., 2012; Andreux et al., 2013; Sanderson et al., 2013).
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